Ciclosporin topical - Spherium Biomed

Drug Profile

Ciclosporin topical - Spherium Biomed

Alternative Names: Ciclosporin 5% topical solution; Cyclosporine 5% topical solution; SP14019; SP14019-F-01

Latest Information Update: 27 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Spherium Biomed
  • Class Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Neuroprotectants
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Atopic dermatitis
  • Clinical Phase Unknown Psoriasis

Most Recent Events

  • 01 Sep 2016 Phase-II clinical trials in Atopic dermatitis in Spain (Topical) (NCT02865356)
  • 29 Aug 2016 Clinical trials in Atopic dermatitis in Spain (Topical) prior to August 2016
  • 29 Aug 2016 Clinical trials in Psoriasis in Spain (Topical) prior to August 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top